ArticleOcular immunology and inflammation

Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation".

Khayyam Durrani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.